64-71 Doc PS Rev Rb
Modes of operation (1) Consideration
shallbe given to the mechanisms and approaches needed to allow the operator to
issue commands to instruments, devices and other aspects of the control system, this
mayinclude things such as
• Face plates
•
Command screens • Button bars
(2) The issuing of commands
shallbe consistent in appearance and approach for all standard modules.
4.10 Regulatory requirements and standards 4.10.1 Regulation and legislative requirements (1) There are two specific sets of regulations that apply to control systems in pharmaceutical environments
•
CFR 21 Part 11 US Code of Federal Regulations, Title 21, Food and Drugs, Part 11 –
Electronic Records, Electronic Signatures Ref. 009]
•
EudraLex Vol 4 Annex 11 EU Regulations Volume 4: Pharmaceutical legislation – Medicinal Products for Human and Veterinary use – Good Manufacturing Ref. 010]
(2) Generally, if a system is compliant with GAMP 5 it will satisfy the EU Regulations Volume 4, Annex 11 23 There are some additional documentation requirements and these are specifically addressed in the Project Validation Plan (VP, Ref. 002].
Doc PS Rev R 65-71
(3)
CFR 21 Part 11 is concerned with the accuracy, reliability and storage of electronic signatures this is more relevant to supervisory systems rather than the Controller software of this Project however, were applicable the PAL software will comply with these regulations.
(4) The legislative and regulatory requirements for the software are set out in this section and the software shall comply
with these requirements (5) In addition to the legislative and regulatory requirements, the software will also conform to the standards specified below
Share with your friends: